We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
- Authors
Nakatake, Richi; Hishikawa, Hidehiko; Kotsuka, Masaya; Ishizaki, Morihiko; Matsui, Kosuke; Nishizawa, Mikio; Yoshizawa, Katsuhiko; Kaibori, Masaki; Okumura, Tadayoshi
- Abstract
<bold>Background/aims: </bold>The proton pump inhibitor lansoprazole (LPZ) is clinically used to reduce gastric acid secretion, but little is known about its possible hepatoprotective effects. This study aimed to investigate the hepatoprotective effects of LPZ and its potential mechanisms using in vitro and in vivo rat models of liver injury.<bold>Methods: </bold>For the in vitro model of liver injury, primary cultured rat hepatocytes were treated with interleukin-1β in the presence or absence of LPZ. The influence of LPZ on inducible nitric oxide synthase (iNOS) induction and nitric oxide (NO) production and on the associated signaling pathways was analyzed. For the in vivo model, rats were treated with D-galactosamine (GalN) and lipopolysaccharide (LPS). The effects of LPZ on survival and proinflammatory mediator expression (including iNOS and tumor necrosis factor-α) in these rats were examined.<bold>Results: </bold>LPZ inhibited iNOS induction partially through suppression of the nuclear factor-kappa B signaling pathway in hepatocytes, thereby reducing potential liver injury from excessive NO levels. Additionally, LPZ increased survival by 50% and decreased iNOS, tumor necrosis factor-α, and cytokine-induced neutrophil chemoattractant-1 mRNA expression in the livers of GalN/LPS-treated rats. LPZ also inhibited nuclear factor-kappa B activation by GalN/LPS.<bold>Conclusions: </bold>LPZ inhibits the induction of several inflammatory mediators (including cytokines, chemokines, and NO) partially through suppression of nuclear factor-kappa B, resulting in the prevention of fulminant liver failure. The therapeutic potential of LPZ for liver injuries warrants further investigation.
- Subjects
PROTON pump inhibitors; NF-kappa B; LIVER injuries; NITRIC-oxide synthases; H2 receptor antagonists; INFLAMMATORY mediators
- Publication
Digestive Diseases & Sciences, 2019, Vol 64, Issue 10, p2854
- ISSN
0163-2116
- Publication type
journal article
- DOI
10.1007/s10620-019-05622-6